Forvis Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Forvis Wealth Advisors, LLC

$3.96 Billion
Q2 2024

A detailed history of Forvis Wealth Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Forvis Wealth Advisors, LLC holds 3,263 shares of REGN stock, worth $2.69 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

3,263

Previous 3,245 0.55%

Holding current value

$2.69 Million

Previous $3.12 Million 9.8%

% of portfolio

0.09%

Previous 0.08%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$883.2 - $1071.19 $15,897 - $19,281	18 Added 0.55%	3,263 $3.43 Million
Q1 2024 Apr 19, 2024	SELL	$902.69 - $993.35 $38,815 - $42,714	-43 Reduced 1.31%	3,245 $3.12 Million
Q4 2023 Jan 11, 2024	SELL	$775.18 - $881.7 $124,803 - $141,953	-161 Reduced 4.67%	3,288 $2.89 Million
Q3 2023 Oct 25, 2023	SELL	$692.45 - $844.37 $1.09 Million - $1.33 Million	-1,574 Reduced 31.34%	3,449 $2.84 Million
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $970,241 - $1.15 Million	1,386 Added 38.11%	5,023 $3.61 Million
Q1 2023 Apr 26, 2023	BUY	$680.49 - $826.97 $61,924 - $75,254	91 Added 2.57%	3,637 $2.99 Million
Q4 2022 Feb 02, 2023	BUY	$705.89 - $766.39 $14,823 - $16,094	21 Added 0.6%	3,546 $2.56 Million
Q3 2022 Oct 13, 2022	BUY	$573.97 - $724.32 $99,870 - $126,031	174 Added 5.19%	3,525 $2.43 Million
Q2 2022 Jul 22, 2022	BUY	$548.35 - $738.84 $123,927 - $166,977	226 Added 7.23%	3,351 $1.98 Million
Q1 2022 May 10, 2022	BUY	$595.12 - $698.43 $217,218 - $254,926	365 Added 13.22%	3,125 $2.18 Million
Q4 2021 Jan 14, 2022	BUY	$543.48 - $670.97 $238,044 - $293,884	438 Added 18.86%	2,760 $1.74 Million
Q3 2021 Oct 14, 2021	BUY	$574.03 - $680.96 $997,664 - $1.18 Million	1,738 Added 297.6%	2,322 $1.41 Million
Q2 2021 Jul 14, 2021	BUY	$472.8 - $558.54 $276,115 - $326,187	584 New	584 $326,000
Q3 2020 Nov 05, 2020	SELL	$544.75 - $658.21 $240,234 - $290,270	-441 Closed	0 $0
Q2 2020 Jul 15, 2020	SELL	$493.32 - $643.92 $274,285 - $358,019	-556 Reduced 55.77%	441 $275,000
Q1 2020 Apr 10, 2020	BUY	$336.18 - $494.43 $335,171 - $492,946	997 New	997 $487,000

Others Institutions Holding REGN

# of Institutions

1,492

Shares Held

85.8M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forvis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forvis Wealth Advisors, LLC with notifications on news.

Account

Forvis Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History